Autolus Therapeutics Plc/ US05280R1005 /
| 2024-05-22 3:55:39 PM | Chg. -0.04 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 3.84USD | -0.90% | 328 Turnover: 1,247.59 |
-Bid Size: - | -Ask Size: - | 3.88 | 3.79 |
GlobeNewswire
05-17
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire
05-14
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in ...
GlobeNewswire
05-13
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
GlobeNewswire
04-24
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of ob...
GlobeNewswire
04-23
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May ...
GlobeNewswire
04-02
Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the Europe...
GlobeNewswire
03-28
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientif...
GlobeNewswire
03-25
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Co...
GlobeNewswire
03-20
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire
03-14
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
GlobeNewswire
03-12
Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certificati...
GlobeNewswire
02-29
Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 20...
Newsfile Corp
02-15
Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
GlobeNewswire
02-08
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire
02-08
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
